Kali Inc To Present Strategy For Entering $50 Billion Cannabis Pharmaceutical Sector In Online Presentation This Friday
October 31 2018 - 8:57AM
InvestorsHub NewsWire
Sarasota, FL -- October 31, 2017 --
InvestorsHub NewsWire -- Kali, Inc. (USOTC:
KALY) today announced an online presentation scheduled Friday,
November 2nd, 2018 to detail the strategy behind the
recently announced plans with Puration, Inc. (USOTC:
PURA) and Nouveau Life Pharmaceuticals, Inc. (USOTC:
NOUV) to form a joint venture (JV) company to develop cannabis
pharmaceutical products. The cannabis pharmaceutical market
is anticipated to reach a value of $50 billion by 2029.
Kali recently announced a letter of
intent to acquire NCM Biotech, the developer and owner of a
patented cannabis extraction process - U.S. Patent No. 9,199,960
entitled “METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT
MATERIALS INCLUDING THE CANNABIS PLANT.” Kali and NCM
anticipate closing the acquisition next month.
Puration has previously licensed the
NCM Biotech patent for use in specific commercial applications.
Puration brings its commercial experience to the planned
pharmaceutical JV.
Nouveau has recently acquired a
cannabis cultivation operation from Puration. In the JV, Nouveau
would be tasked with developing a proprietary pharmaceutical grade
hemp cultivar.
Frederick Ferri, CEO and Founder of
NCM Biotech notes, “Some feedback has specifically indicated that a
number of our candidate pharmaceutical products under development
have a greater efficacy potential than GW
Pharmaceutical [GWPH]
products and candidate products.“
NCM
Biotech’s medical advisory team includes John N.
Gaitanis, MD., Director of Child Neurology at Tufts Medical
Center/Floating Hospital for Children; Lloyd R. Saberski,
M.D., Associate Professor of Anesthesiology and Chronic Pain
Management, Yale University, and John McMichael, Ph.D., President
& CEO Beech Tree Labs.
Learn more about NCM Biotech at
https://www.ncmbiotech.com/
Representatives of the three
companies plan to meet next week in Dallas, Texas at Puration’s
headquarters.
This press release contains
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"),
and as such, may involve risks and uncertainties. These forward
looking statements relate to, amongst other things, current
expectation of the business environment in which the company
operates, potential future performance, projections of future
performance and the perceived opportunities in the market. The
company's actual performance, results and achievements may differ
materially from the expressed or implied in such forward-looking
statements as a result of a wide range of
factors.
CONTACT:
Kali, Inc.
941.444.6994
management@wavemarineservices.com
Kali (CE) (USOTC:KALY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Kali (CE) (USOTC:KALY)
Historical Stock Chart
From Apr 2023 to Apr 2024